Results 51 to 60 of about 13,139 (150)
Outcomes of Hindfoot and Ankle Arthrodesis in Patients with Charcot Neuroarthropathy [PDF]
Background. Involvement of the hindfoot and ankle in diabetic Charcot neuroarthropathy is often associated with subtotal or total defects of the talus, leading to unstable multiplanar deformities and a significant loss of weight-bearing capacity in the ...
Vladimir A. Vinogradov +7 more
doaj +1 more source
ABSTRACT Introduction Therapeutic orthoses, such as medical shoes and custom insoles, are used to prevent diabetic foot ulcer (DFU) recurrence. This systematic review with narrative synthesis aimed to evaluate the effectiveness of orthoses in preventing DFU recurrence compared to standard care.
Behnam Amini +2 more
wiley +1 more source
Risk of Venous Thromboembolism in People Affected by Charcot Foot Treated With Total Contact Cast
ABSTRACT Aims Charcot Foot (CF) is a neuropathy‐induced condition that can lead to fractures and dislocation, warranting long‐time offloading in total contact cast (TCC). It is unknown whether CF or its treatment increases the risk of venous thromboembolism (VTE).
Johan Schoug +3 more
wiley +1 more source
Charcot Neuroarthropathy After Simultaneous Pancreas-Kidney Transplant
Background. Immunosuppressive regimen is associated with several metabolic adverse effects. Bone loss and fractures are frequent after transplantation and involve multifactorial mechanisms.Methods.
Rangel, Erika B. [UNIFESP] +7 more
core +1 more source
Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study
Background Charcot neuroarthropathy (Charcot foot) is a highly destructive joint disease of the foot and ankle. If there is delayed diagnosis and treatment, it can lead to gross deformity, instability, recurrent ulceration and/or amputation.
Danielle A. Griffiths +1 more
doaj +1 more source
ABSTRACT A 58‐year‐old man with diabetes, end‐stage renal disease, and severe peripheral arterial disease had a chronic ischemic foot ulcer refractory to one year of conventional therapy. Injectable collagen‐based regenerative therapy produced complete epithelialization within three months and durable limb salvage, even after a thermally induced ...
Ma'moun Qawasmeh +4 more
wiley +1 more source
Lower serum zinc levels were independently associated with distal symmetric polyneuropathy in patients with type 2 diabetes mellitus. Each 1 μg/dL increase in serum zinc level was associated with a 5.4% reduction in the odds of diabetic neuropathy, suggesting a potential role of zinc deficiency in DSPN pathogenesis.
Hosseinali Mohammadi +2 more
wiley +1 more source
Bibliometric Analysis of Charcot Arthropathy (1995–2025): Current Status and Emerging Trends
ABSTRACT Background Charcot Arthropathy (CA) is a destructive joint condition tied to neurotrophic and neuropathic processes. The clinical course is often complicated—high amputation rates and a generally poor prognosis have long made management difficult.
Jian Lin Zhou, Hao Peng, Fei Sun
wiley +1 more source
The Effect of Zoledronic Acid on the Clinical Resolution of Charcot Neuroarthropathy
OBJECTIVE To investigate the clinical efficacy of zoledronic acid in patients with diabetes and acute Charcot neuroarthropathy. RESEARCH DESIGN AND METHODS
Heikki-Jussi Laine +4 more
core +1 more source
Charcot neuroarthropathy is a destructive, chronic disease of the bone structure and joints, and is identified in patients experiencing peripheral neuropathy, frequently associated with diabetes.
Jeffrey Loveland, DPM, FACFAS +1 more
doaj +1 more source

